Two Partners Come Together to Manufacture Gene Therapy for RPGRIP1-Related Vision Disorders
source: unsplash.com

Two Partners Come Together to Manufacture Gene Therapy for RPGRIP1-Related Vision Disorders

According to a story from World Pharma Today, Andelyn Biosciences, Inc., which is a gene therapy Contract Development and Manufacturing Organization (CDMO), has recently struck a partnership with Odylia Therapeutics,…

Continue Reading Two Partners Come Together to Manufacture Gene Therapy for RPGRIP1-Related Vision Disorders

Humane Lab Testing in Dogs Leads to a Possible Cure for Leber Congenital Amaurosis (LCA) in Humans

Veterinary ophthalmologists at Pennsylvania’s Veterinarian School of Medicine found that LCA in humans mimics the same type of disease in dogs. According to a recent article in Science Daily, vision…

Continue Reading Humane Lab Testing in Dogs Leads to a Possible Cure for Leber Congenital Amaurosis (LCA) in Humans

The World’s First Editing of DNA in Humans Using CRISPR to Treat Leber Congenital Amaurosis

  Allergan plc, a leading global pharmaceutical company, and its partner, Editas Medicine, Inc. have been given the green light for a clinical trial designed to treat patients with severe…

Continue Reading The World’s First Editing of DNA in Humans Using CRISPR to Treat Leber Congenital Amaurosis
As Gene Therapy Becomes a Reality, Spark Therapeutics Looks at Challenges That Still Remain
geralt / Pixabay

As Gene Therapy Becomes a Reality, Spark Therapeutics Looks at Challenges That Still Remain

According to a story from BioPharma Dive, the advent of gene therapy development at Spark Therapeutics has been five years in the making. At this juncture, it has been nearly…

Continue Reading As Gene Therapy Becomes a Reality, Spark Therapeutics Looks at Challenges That Still Remain
ICYMI: FDA In Favor Of Luxturna, A Gene Therapy For Leber Congenital Amaurosis
Source: Pixabay

ICYMI: FDA In Favor Of Luxturna, A Gene Therapy For Leber Congenital Amaurosis

The FDA, US Food and Drug Administration, unanimously agreed upon the recommendation for a new gene therapy that treats a rare form of blindness, reported ScienceNordic. Spark Therapeutics, a biotech…

Continue Reading ICYMI: FDA In Favor Of Luxturna, A Gene Therapy For Leber Congenital Amaurosis
ICYMI: FDA Makes History Aproving a Gene Therapy That Can Improve Childhood Blindness
Source: Pixabay

ICYMI: FDA Makes History Aproving a Gene Therapy That Can Improve Childhood Blindness

According to The Washington Post, on Tuesday the Food and Drug Administration, FDA, made history by approving a gene therapy for childhood blindness, which will change the lives of many…

Continue Reading ICYMI: FDA Makes History Aproving a Gene Therapy That Can Improve Childhood Blindness
Company Developing Treatment for Rare Childhood Blindness Gets Special FDA Designation
Source: Pixabay

Company Developing Treatment for Rare Childhood Blindness Gets Special FDA Designation

The FDA has granted a special designation for a drug company developing a gene therapy for the treatment of leber congenital amaurosis (LCA). MeiraGTx received rare pediatric disease designation for its…

Continue Reading Company Developing Treatment for Rare Childhood Blindness Gets Special FDA Designation
“Fishing” for a Cure for Leber Congenital Amaurosis
https://pixabay.com/en/fisherman-boat-inle-lake-myanmar-239487/

“Fishing” for a Cure for Leber Congenital Amaurosis

By examining a zebrafish, scientists have found the gene that affects the maintenance of cone photoreceptors and visual functions in the eye. It might be the knowledge that’s been needed…

Continue Reading “Fishing” for a Cure for Leber Congenital Amaurosis
A New Treatment May Be Coming for Leber Congenital Amaurosis
https://pixabay.com/en/eye-iris-macro-natural-girl-2340806/

A New Treatment May Be Coming for Leber Congenital Amaurosis

Case Western Reserve University researchers have recently developed gene-carrying nanoparticles that are able to bring healthy genes to those negatively affected by Leber congenital amaurosis (LCA), a disease that causes…

Continue Reading A New Treatment May Be Coming for Leber Congenital Amaurosis